THNR Amplify Weight Loss Drug & Treatment ETF

Share ▾
Share on XDownload as PDF
$24.72
+0.4% · 1 day, price
IQ’s readingComputed nightly from ETFIQ data. Not written live.

Over the year to Oct 28, 2026, THNR returned 8.4%.

Holds 21 stocks in healthcare innovation and GLP-1, 45% of its weight in S&P 500 companiesAmplify ↗Expense ratio 0.59%Fund assets $5.7m on Oct 28, 2026First traded May 21, 2024Benchmark Its own holdings, as of Oct 28, 2026; its filing names the VettaFi Weight Loss Drug & Treatment Index, and it files no N-CEN, so no other fund is measured against it as tracking that indexFund page at the issuer ↗SEC filings ↗Every Amplify fund ETFIQ coversDividend history

Promise check: Not measuredIts theme exposure is measured once ETFIQ defines its theme company by company.

THNR risk and return scorecard

vs its own holdings

Not measured: its benchmark is its own holdings, which has no weekly price series.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records; risk-free rate: U.S. Treasury, Daily Treasury Bill Rates, 13-week coupon equivalent Method · Data

Money in and out

Net fund flows · Oct 26, 2026
Last 4 trading days
$0
12 months to Jun 30, 2026
+$992k
May 2024 to Jun 2026
+$4.6m
No money in or out. 49 days missing.

What you earned

THNR −2.4%: total return over one month to Oct 28, 2026.
THNR−2.4%
THNR −4.1%: total return over three months to Oct 28, 2026.
THNR−4.1%
THNR +4.8%: total return over six months to Oct 28, 2026.
THNR+4.8%
THNR −2.0%: total return over the year to Oct 28, 2026.
THNR−2.0%
THNR +8.4%: total return over one year to Oct 28, 2026.
THNR+8.4%
THNR −0.1%: total return since launch to Oct 28, 2026.
THNR−0.1%

What did you actually buy?

Healthcare innovation and GLP-1 · holdings as of Oct 28, 2026
45.3%
Already in the S&P 500
96.5%
Active share vs the S&P 500
65.7%
Top ten holdings
+8.4%
Total return, 1 year
1.8%
12-month yield, capital gains included, on its starting price
$0.4132
Last payment, ex-date Dec 30, 2025
Share already in the S&P 500
45.3% of the fund by weight, holdings as of Oct 28, 2026.
Ten largest holdings
Eli Lilly & Co11.4%
Novo Nordisk A/S8.7%
Amgen Inc6.3%
Roche Holding AG6.0%
AbbVie Inc5.8%
Gilead Sciences Inc5.7%
Pfizer Inc5.7%
AstraZeneca PLC5.6%
Regeneron Pharmaceuticals Inc5.4%
Chugai Pharmaceutical Co Ltd5.2%

More on THNR

Every number below is on this page. Open what you need.

THNR flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Price, 1 year

$24.72+0.4%1 day, priceClose, Oct 28, 2026

Price only. Total return over the same days, distributions reinvested, was +8.4%. Computed by ETFIQ from Tiingo daily prices.

Source: Tiingo end-of-day prices. Data as of Oct 28, 2026. Updated every trading night. Report a data error

THNR returns by window: total return, cash paid and price change
WindowTotal returnS&P 500 (SPY)
1M Sep 28 – Oct 28, 2026−2.4%+0.9%
3M Jul 29 – Oct 28, 2026−4.1%+6.1%
6M Apr 29 – Oct 28, 2026+4.8%+9.1%
YTD Dec 31, 2025 – Oct 28, 2026−2.0%+14.1%
1Y Oct 28, 2025 – Oct 28, 2026+8.4%+13.6%
Since launch May 21, 2024 – Oct 28, 2026−0.1%+49.6%
Since launch, annualised May 21, 2024 – Oct 28, 2026−0.1%–

Total returns, distributions reinvested. Listed May 2024: no 3 years windows.

Source: Tiingo end-of-day prices, with distributions reinvested.

Money in and out

Daily data · as of Oct 26, 2026

THNR: in the 16 trading days to Oct 26, 2026, nothing net moved.

4D
$0
0.0% of $5.8m on Oct 20, 2026
Oct 21, 2026 to Oct 26, 2026
12 months
+$992k
33.7% of $2.9m on Jun 30, 2025
Jul 1, 2025 to Jun 30, 2026
monthly, from SEC filings
May 2024 to Jun 2026
+$4.6m
May 1, 2024 to Jun 30, 2026
monthly, from SEC filings
Net flow each trading day
Net flow into THNR each trading day, Jul 28, 2026 to Oct 26, 2026monthly, from SEC filingsdaily, from AmplifyJul 28, 2026Oct 26, 2026

THNR, net flow each trading day over the 64 sessions from Jul 28, 2026 to Oct 26, 2026: money came in on 0 days and went out on 0 days, of the 15 days with daily data; the other 49 have none. Before Oct 6, 2026 ETFIQ has the fund’s monthly data only, from SEC filings: that span is shaded and draws no bars, and its months are in the month by month list.

No money in or out. 49 days missing.

Net flow into THNR each trading day, Oct 28, 2025 to Oct 26, 2026monthly, from SEC filingsdaily, from AmplifyOct 28, 2025Oct 26, 2026

THNR, net flow each trading day over the 250 sessions from Oct 28, 2025 to Oct 26, 2026: money came in on 0 days and went out on 0 days, of the 15 days with daily data; the other 235 have none. Before Oct 6, 2026 ETFIQ has the fund’s monthly data only, from SEC filings: that span is shaded and draws no bars, and its months are in the month by month list.

No money in or out. 235 days missing.

Net flow into THNR each trading day, Mar 25, 2025 to Oct 26, 2026monthly, from SEC filingsdaily, from AmplifyMar 25, 2025Oct 26, 2026

THNR, net flow each trading day over the 400 sessions from Mar 25, 2025 to Oct 26, 2026: money came in on 0 days and went out on 0 days, of the 15 days with daily data; the other 385 have none. Before Oct 6, 2026 ETFIQ has the fund’s monthly data only, from SEC filings: that span is shaded and draws no bars, and its months are in the month by month list.

No money in or out. 385 days missing.

Money in, netMoney out, netMonthly basis

Daily data starts Oct 6, 2026.

How this is computed

Computed by ETFIQ from Amplify’s daily data: each day’s change in shares outstanding times the previous day’s net asset value. Percentages are of net assets at the start of each window. Numbers are net: money in less money out. Every day and month ETFIQ holds for THNR, back to May 2024, is in its flows file. Flows across every fund · How these flows are computed · Compare THNR with other funds in the flows tool

Every trading day, last 3 months15 days
Oct 26, 2026 $0
Oct 23, 2026 $0
Oct 22, 2026 $0
Oct 21, 2026 $0
Oct 20, 2026 $0
Oct 19, 2026 $0
Oct 16, 2026 $0
Oct 15, 2026 $0
Oct 14, 2026 $0
Oct 13, 2026 $0
Oct 12, 2026 $0
Oct 9, 2026 $0
Oct 8, 2026 $0
Oct 7, 2026 $0
Oct 6, 2026 $0 covers 2 trading days

Most recent first.

Week by week, last year4 weeks
Oct 26, 2026 $0 1 day
Oct 23, 2026 $0
Oct 16, 2026 $0
Oct 9, 2026 $0 4 days

Net flow into THNR each week, Oct 6, 2026 to Oct 26, 2026, most recent first, each week named by its last trading day with data. Computed by ETFIQ.

Month by month, money in and money outMay 2024 to Oct 2026

THNR, money in and money out each month from May 2024 to Jun 2026: two bars a month, money in above the line and money out below. Every bar is from THNR’s SEC filings (N-PORT item B.6). Oct 2026 is still in progress, so it is in the list and not drawn. Of the 27 months listed, money came in on net in 7 and went out in 4.

Every bar is from THNR’s SEC filings (N-PORT item B.6). Of the 27 months listed, money came in on net in 7 and went out in 4.

MonthInOutNet
Oct 2026 ETFIQ, the sum of its days, Oct 6 to Oct 26$0$0$0
Jun 2026 SEC Form N-PORT$0$0$0
May 2026 SEC Form N-PORT$0$0$0
Apr 2026 SEC Form N-PORT$0$0$0
Mar 2026 SEC Form N-PORT$0$0$0
Feb 2026 SEC Form N-PORT+$519k$0+$519k
Jan 2026 SEC Form N-PORT+$1.0m$0+$1.0m
Dec 2025 SEC Form N-PORT$0$0$0
Nov 2025 SEC Form N-PORT$0$0$0
Oct 2025 SEC Form N-PORT$0−$493k−$493k
Sep 2025 SEC Form N-PORT$0−$1.2m−$1.2m
Aug 2025 SEC Form N-PORT+$1.1m$0+$1.1m
Jul 2025 SEC Form N-PORT$0$0$0
Jun 2025 SEC Form N-PORT$0$0$0
May 2025 SEC Form N-PORT$0−$444k−$444k
Apr 2025 SEC Form N-PORT$0−$605k−$605k
Mar 2025 SEC Form N-PORT$0$0$0
Feb 2025 SEC Form N-PORT$0$0$0
Jan 2025 SEC Form N-PORT$0$0$0
Dec 2024 SEC Form N-PORT$0$0$0
Nov 2024 SEC Form N-PORT$0$0$0
Oct 2024 SEC Form N-PORT$0$0$0
Sep 2024 SEC Form N-PORT+$1.1m$0+$1.1m
Aug 2024 SEC Form N-PORT+$525k$0+$525k
Jul 2024 SEC Form N-PORT$0$0$0
Jun 2024 SEC Form N-PORT+$1.6m$0+$1.6m
May 2024 SEC Form N-PORT+$1.5m$0+$1.5m

Most recent first.

How this is computed

N-PORT months: money in is sales plus reinvestments; money out is redemptions. Months summed from daily data: money in adds the days money came in; money out adds the days it went out.

N-PORT months are the filed sales plus reinvestments less redemptions. Later months add up the daily data; the Source column names any missing day.

Source: ETFIQ, from the fund’s daily share counts and net asset values, and its SEC N-PORT filings. Data as of Oct 26, 2026. Last checked Oct 29, 2026.

THNR key stats

52-week high, daily closes to Oct 28, 2026 (ETFIQ)$27.91 on Aug 25, 2026
52-week low, daily closes to Oct 28, 2026 (ETFIQ)$22.94 on Oct 29, 2025
Close on Oct 28, 2026, within that range (ETFIQ)$24.72, 36% of the way from the low to the high
Holdings21
Top ten holdings weight65.7%
Range, beta and R-squared computed by ETFIQ from Tiingo daily prices.

Trading

as of Oct 28, 2026
Trading · THNRas of Oct 28, 2026
·
Not scored2 of 6 measured · Oct 28, 2026
0 · Hard to tradeIQ Liquidity Score100 · Trades like a giant
Cost for your order · one way, half its 30-day median spread
$1,000$1.400.14%
$10,000$140.14%
Premium or discount to NAV, Oct 28 close+0.12%
−0.4%95% of days within ±0.29% · the 1% band is off this scale+0.4%
How to tradeLimit: midpoint + 4¢ to buy, midpoint − 4¢ to sell.At the Oct 28 close of $24.72, that’s $24.76 to buy and $24.68 to sell.
Full trading page: components, premium history, dealers →

THNR top ten by weight, 65.7% of the fund, of its 21 equity positions, from the holdings published by its issuer for Oct 28, 2026. Source: the issuer’s own daily file.

Eli Lilly & Co LLY 11.41%
Novo Nordisk A/S NVO 8.65%
Amgen Inc AMGN 6.27%
Roche Holding AG ROP SWX 5.99%
AbbVie Inc ABBV 5.79%
Pfizer Inc PFE 5.65%
AstraZeneca PLC AZN 5.64%

Source: Amplify’s daily holdings file. Updated each trading day. Last checked Oct 28, 2026.

About THNR

Theme (ETFIQ, editorial)Healthcare innovation and GLP-1
First tradedMay 21, 2024
Already in the S&P 500, by weight (ETFIQ)45.3%
Outside the S&P 500, by weight (ETFIQ)55%
Active share vs the S&P 500 (ETFIQ)96.5%
Already in the Nasdaq-100, by weight (ETFIQ)17.4%
Active share vs the Nasdaq-100 (ETFIQ)98.2%
Top ten holdings weight65.7%
Holdings21
Holdings published for (the issuer’s daily file)Oct 28, 2026
Holdings as of the close of (the issuer’s daily file)Oct 28, 2026
Top holdingsEli Lilly & Co 11.4%, Novo Nordisk A/S 8.7%, Amgen Inc 6.3%, Roche Holding AG 6.0%, AbbVie Inc 5.8%, Gilead Sciences Inc 5.7%, Pfizer Inc 5.7%, AstraZeneca PLC 5.6%, Regeneron Pharmaceuticals Inc 5.4%, Chugai Pharmaceutical Co Ltd 5.2%
Net assets (issuer page, as of Oct 28, 2026)$5.7mReport
Benchmark (ETFIQ, from its filings)Its own holdings, as of Oct 28, 2026; its filing names the VettaFi Weight Loss Drug & Treatment Index, and it files no N-CEN, so no other fund is measured against it as tracking that index
Below its all-time high (ETFIQ)−11.4%
Expense ratio (485BPOS XBRL, Jan 28, 2026)0.59%Report
Fee for the part that differs from the S&P 500, active expense ratio (ETFIQ)0.61%
Closest funds by holdings overlapOZEM 68%, PBPH 49%, AGNG 21%, GDOC 19%, IBBQ 18%
Below its all-time high11.4%, high on Aug 25, 2026
How we measure
The top ten holdings are 66% of the fund across 21 positions, as published by its issuer for Oct 28, 2026. Over the year to Oct 28, 2026 the fund returned +8.4% with distributions reinvested. It sits 11.4% below its all-time high of Aug 25, 2026.
Holdings from the file the issuer publishes daily; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. Method
IQ Investment Committee on THNR

12 seats on THNR, as of Oct 28, 2026: 8 Challenges, 4 Not enough data.

In the tradition ofJohn BogleBogle-style Low CostChallenges
In the tradition ofBenjamin GrahamGraham-style Margin of SafetyNot enough data
In the tradition ofWarren Buffett & Charlie MungerBuffett & Munger-style QualityNot enough data
In the tradition ofPeter LynchLynch-style Growth at a Reasonable PriceNot enough data
In the tradition ofJohn TempletonTempleton-style Global ContrarianNot enough data
In the tradition ofRay DalioDalio-style All-WeatherChallenges
In the tradition ofHoward MarksMarks-style Cycles & RiskChallenges
In the tradition ofStanley DruckenmillerDruckenmiller-style Macro & LiquidityChallenges
In the tradition ofDavid SwensenSwensen-style DiversificationChallenges
In the tradition ofCathie WoodWood-style Disruptive InnovationChallenges
In the tradition ofJesse LivermoreLivermore-style Trend FollowingChallenges
Uses ETFIQ’s measuresThe ETFIQ SkepticETFIQ’s own seatChallenges
Put THNR to the committee →See all seats →No investor named is affiliated with or endorses ETFIQ. Not investment advice.

Questions people ask about THNR

How much of THNR is in S&P 500 companies?
By its holdings published by its issuer for Oct 28, 2026, 45% of THNR by weight is stocks the S&P 500 already holds. Its active share against the index is 96%, so that share is the part doing something different.
What does THNR hold?
21 positions as published by its issuer for Oct 28, 2026, with the top ten at 66% of the fund. The largest are Eli Lilly & Co at 11.4%, Novo Nordisk A/S at 8.7%, Amgen Inc at 6.3%.
Has THNR beaten the S&P 500?
Over the year to Oct 28, 2026 THNR returned +8.4% with distributions reinvested, against +13.6% for the S&P 500, so it finished behind the index by 5.2 points.
What does THNR cost?
The prospectus expense ratio is 0.59% a year. Because 96% of the fund differs from the S&P 500, the fee on that differing part works out at 0.61%.
Sources and dates
Prices, THNR and S&P 500 (SPY)Tiingo end-of-day · Oct 28, 2026
Net assets, $5.7mIssuer page · Oct 28, 2026

Links are sources, not endorsements.

Cite this pageCitation, APA and Markdown

ETFIQ, THNR, thematic ETFs, data as of Oct 28, 2026. https://etfiq.com/funds/thnr

The difference bar for THNR, redrawn every trading night.

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

How differently the money is placed, counting weights: one minus the sum of the smaller weight of each security across the fund and the index. 100% means nothing in common; 0% means the index itself. Two funds can hold the same names and still have a high active share if they weight them very differently.
Weight overlap
The share of money two portfolios hold in the same securities at the same weight.
Already in the index
The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at different weights.
The weight of the ten largest holdings. Above 50% the fund is a bet on a handful of companies, whatever the theme.
Embed this chart

Free to use with the credit link. Paste this where the chart should go; it updates every trading night.

THNR: 45% of THNR's weight is in S&P 500 companies and 55% is outside the index. Holdings as of Oct 28, 2026.
<figure style="margin:0;max-width:640px">
<a href="https://etfiq.com/funds/thnr"><img src="https://etfiq.com/assistant/api/embed/themes/thnr.svg" alt="THNR: 45% of THNR&#x27;s weight is in S&amp;P 500 companies and 55% is outside the index. Holdings as of Oct 28, 2026." width="640" style="max-width:100%;height:auto"></a>
<figcaption style="font:13px/1.5 sans-serif">THNR: 45% of THNR&#x27;s weight is in S&amp;P 500 companies and 55% is outside the index. Holdings as of Oct 28, 2026. Data: <a href="https://etfiq.com/funds/thnr">ETFIQ</a></figcaption>
</figure>

How to embed ETFIQ charts

Get the ETFIQ Daily

The day's ETF flows, a comparison and one number. Every trading morning. About the Daily

The ETFIQ Daily and our other emails. Unsubscribe from any one in a click. See Privacy.

Snapshot, Oct 28, 2026. More on the tabs above.